COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,051 Articles (22,627 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 1367: Articles 13661-13670  | Next

Elucidating Post-COVID-19 manifestations in India
Fatima, G., Bhatt, D., Idrees, J., Khalid, B., Mahdi, F.
10.1101/2021.07.06.21260115 — Posted: 2021-07-08
REACT-1 round 13 interim report: acceleration of SARS-CoV-2 Delta epidemic in the community in England during late June and early July 2021
Riley, S., Eales, O., Haw, D., Wang, H., Walters, C. E., Ainslie, K. E. C., Atchinson, C., Fronterre, C., Diggle, P. J., Ashby, D., Donnelly, C. A., Barclay, W., Cooke, G., Ward, H., Darzi, A., Elliott, P.
10.1101/2021.07.08.21260185 — Posted: 2021-07-08
Heparin for Moderately Ill Patients with Covid-19
Sholzberg, M., Tang, G. H., Rahhal, H., AlHamzah, M., Baumann Kreuziger, L., Ni Ainle, F., Alomran, F., Alayed, K., AlSheef, M., AlSumait, F., Pompilio, C. E., Sperlich, C., Tangri, S., Tang, T., Jaksa, P. J., Suryanarayan, D., Almarshoodi, M. O., Castellucci, L. A., James, P. D., Lillicrap, D., Carrier, M., Beckett, A., Colovos, C., Jayakar, J., Arsenault, M.-P., Wu, C., Doyon, K., Andreou, E. R., Dounaevskaia, V., Tseng, E. K., Lim, G., Fralick, M., Middeldorp, S., Lee, A. Y. Y., Zuo, F., da Costa, B. R., Thorpe, K. E., Negri, E. M., Cushman, M., Jüni, P., RAPID Trial investigators
10.1101/2021.07.08.21259351 — Posted: 2021-07-08
Image and structured data analysis for prognostication of health outcomes in patients presenting to the Emergency Department during the COVID-19 pandemic
Butler, L., Karabayir, I., Tootooni, M. S., Afshar, M., Goldberg, A., Akbilgic, O.
10.1101/2021.07.07.21260097 — Posted: 2021-07-08
Ultrastructural analysis of nasopharyngeal epithelial cells from patients with SARS-CoV-2 infection
Saraiva, K. L., Vasconcelos, L. R., Bezerra, M. F., Arcoverde, R. M., Brandao-Filho, S. P., Ayres, C. F., Figueiredo, R. C., Pereira-Neves, A.
10.1101/2021.07.08.451607 — Posted: 2021-07-08
Evaluation of intranasal nafamostat or camostat for SARS-CoV-2 chemoprophylaxis in Syrian golden hamsters
Neary, M., Box, H., Sharp, J., Tatham, L., Curley, P., Herriott, J., Kijak, E., Arshad, U., Hobson, J. J., Rajoli, R. K., Pertinez, H., Valentijn, A., Dhaliwal, K., McCaughan, F., Rannard, S. P., Kipar, A., Stewart, J. P., Owen, A.
10.1101/2021.07.08.451654 — Posted: 2021-07-08
Atomistic Simulations and Deep Mutational Scanning of Protein Stability and Binding Interactions in the SARS-CoV-2 Spike Protein Complexes with Nanobodies: Molecular Determinants of Mutational Escape Mechanisms
Verkhivker, G., Agajanian, S., Oztas, D. Y., Gupta, G.
10.1101/2021.07.07.451538 — Posted: 2021-07-08
Antibody and T cell memory immune response after two doses of the BNT162b2 mRNA vaccine in older adults with and without prior SARS-CoV-2 infection
Demaret, J., Corroyer-Simovic, B., Alidjinou, E. K., Goffard, A., Trauet, J., Miczek, S., Vuotto, F., Dendooven, A., Huvent-Grelle, D., Podvin, J., Dreuil, D., Faure, K., Deplanque, D., Bocket, L., Duhamel, A., Labreuche, J., Sobaszek, A., Puisieux, F., Labalette, M., Lefevre, G.
10.1101/2021.07.08.451426 — Posted: 2021-07-08
In Silico Defined SARS-CoV2 Epitopes May Not Predict Immunogenicity to COVID19
Pan, K., Chiu, Y., Chen, M., Wang, J., Lai, I., Singh, S., Shaw, R. M., Yee, C.
10.1101/2021.07.08.451555 — Posted: 2021-07-08
Structure of a germline-like human antibody defines a neutralizing epitope on the SARS-CoV-2 spike NTD
Altomare, C. G., Adelsberg, D. C., Carreno, J. M., Sapse, I. A., Amanat, F., Ellebedy, A., Simon, V., Krammer, F., Bajic, G.
10.1101/2021.07.08.451649 — Posted: 2021-07-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).